Event │ Precision Medicine World Conference
January 21, 2020 - January 24, 2020
Santa Clara, CA
Greg Michelotti, Ph.D., Scientific Director, Metabolon, Inc.
Leveraging The Power Of Metabolomics For Microbiome Analysis
January 23, 2020 at 1 PM, Track 5
Perturbations in the microbiome have been identified as driving factors in several diseases. Microbes interact with their host through biochemical messaging placing metabolomic profiling at the center for helping elucidate the role of the microbiome in human health. Recent advances in this area will be discussed.
Cynthia Lawley, Ph.D., Population Health, Metabolon, Inc.
Metabolomics As A Functional Readout Of Wellness In The Context Of Polygenic Risk
Wellness and Aging Showcase
Genetic insights have advanced our ability to stratify populations via polygenic risk. We discuss multi-omics and untargeted metabolomics as powerful tools to capture phenotype in the context of genetic risk. These tools guide researchers to advance preventative and individualized healthcare.